Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Sporadic inclusion body myositis: new insights and potential therapy.
[inclusion body myositis]
To
describe
new
insights
and
developments
in
the
pathogenesis
,
diagnosis
and
treatment
of
sporadic
inclusion
body
myositis
(
IBM
)
.
Various
hypothesis
about
the
pathogenesis
of
IBM
continue
to
be
investigated
,
including
autoimmune
factors
,
mitochondrial
dysfunction
,
protein
dyshomeostasis
,
altered
nucleic
acid
metabolism
,
myonuclear
degeneration
and
the
role
of
the
myostatin
pathway
.
Serum
autoantibodies
against
cytosolic
5
'
-
nucleotidase
1
A
have
been
identified
in
IBM
showing
moderate
diagnostic
performance
.
The
differential
diagnostic
value
of
histopathological
features
,
including
different
protein
aggregates
,
continues
to
be
evaluated
.
MRI
may
also
be
of
monitoring
value
in
IBM
.
New
therapeutic
strategies
are
being
tested
in
IBM
patients
,
namely
the
upregulation
of
the
heat
shock
response
and
the
antagonism
of
myostatin
.
Recent
important
advances
have
occurred
in
IBM
.
These
advances
,
including
recent
and
ongoing
clinical
trials
,
may
lead
to
earlier
diagnosis
and
improved
understanding
and
treatment
of
the
disease
.
Despite
improved
knowledge
,
IBM
continues
to
be
a
puzzling
disease
and
the
pathogenesis
remains
to
be
clarified
.
An
interdisciplinary
,
bench
to
bedside
translational
research
approach
is
crucial
for
the
successful
identification
of
novel
treatments
for
this
debilitating
,
currently
untreatable
disorder
.
Diseases
Validation
Diseases presenting
"may lead to earlier diagnosis and improved understanding and treatment of the disease"
symptom
inclusion body myositis
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom